Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
  1. SC 13G/A Stake Amended Statement of Ownership
  2. 8-K Event Executive or director change
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 8-K Event Executive or director change
  11. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $15.00 ($45,000)
  12. 4 Grant or award President and CEO acquired 468 shares (grant or award)
  13. 4 Grant or award General Counsel acquired 979 shares (grant or award)
  14. CT ORDER Other Confidential Order
  15. CT ORDER Other Confidential Order
  16. S-3 Offering Registration Statement
  17. 8-K Event Results of operations
  18. 10-Q Report Quarterly Report
  19. 4 Open-market sale Chief Financial Officer sold 3,000 shares at $15.00 ($45,000)
  20. 4 Open-market sale President and CEO sold 6,526 shares at an average $15.00 ($97,899)

Page 25 of 41 · 801 filings